Results 251 to 260 of about 3,049,300 (294)

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Who Obtains Informed Consent for Endovascular Thrombectomy in Acute Stroke? A Survey of Clinicians. [PDF]

open access: yesNeurohospitalist
Mbonde AA   +11 more
europepmc   +1 more source

Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen   +11 more
wiley   +1 more source

Development of a multimedia informed consent tool for fixed prosthodontic treatment: A cognitive theory-based approach to enhance patient understanding. [PDF]

open access: yesPEC Innov
Ndagire B   +8 more
europepmc   +1 more source

Informed consent MAR

open access: green
Toro-Mayorga, Lorena
openalex   +1 more source

Informed consent is almost impossible

open access: yesHemaSphere
Louise Caldwell, Stephen P. Hibbs
doaj   +1 more source

Home - About - Disclaimer - Privacy